Expert Opinion on Drug Safety, Volume 20, Issue 4 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 20, Issue 4 (2021)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Volume 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Bosutinib – related pleural effusion in patients with chronic myeloid leukemia
Mebrure Burçak Yüzbaşıoğlu & Ahmet Emre Eşkazan
Pages: 379-381
Published online: 08 Jan 2021
First Page PreviewforBosutinib – related pleural effusion in patients with chronic myeloid leukemia | Full Text | References | PDF (206.6 KB) | EPUB
  • 2025 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia
Francesco Panzuto, Ludovica Magi & Maria Rinzivillo
Pages: 383-386
Published online: 02 Feb 2021
First Page PreviewforExocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia | Full Text | References | PDF (420.7 KB) | EPUB
  • 1859 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Drug safety evaluation

Article
Safety evaluation of emicizumab prophylaxis in individuals with haemophilia A
Cassandra P. Wang, Guy Young & Courtney D. Thornburg
Pages: 387-396
Published online: 27 Feb 2021
AbstractforSafety evaluation of emicizumab prophylaxis in individuals with haemophilia A | Full Text | References | PDF (631.6 KB) | EPUB
  • 710 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Risks and benefits of reducing the number of drugs to treat HIV-1 infection
Julen Cadiñanos, Rocio Montejano, Rosa de Miguel Buckley, Cristina Marcelo & Jose R. Arribas
Pages: 397-409
Published online: 24 Feb 2021
AbstractforRisks and benefits of reducing the number of drugs to treat HIV-1 infection | Full Text | References | PDF (427.7 KB) | EPUB
  • 571 Views
  • 10 CrossRef citations
  • 0Altmetric
A safety review of drug treatments for patients with systemic immunoglobulin light chain (AL) amyloidosis
Mario Nuvolone, Marco Basset & Giovanni Palladini
Pages: 411-426
Published online: 07 Mar 2021
AbstractforA safety review of drug treatments for patients with systemic immunoglobulin light chain (AL) amyloidosis | Full Text | References | PDF (443.8 KB) | EPUB
  • 313 Views
  • 1 CrossRef citations
  • 0Altmetric
The safety of current pharmacotherapeutic strategies for osteosarcoma
Mariella Spalato & Antoine Italiano
Pages: 427-438
Published online: 03 Feb 2021
AbstractforThe safety of current pharmacotherapeutic strategies for osteosarcoma | Full Text | References | PDF (399.9 KB) | EPUB
  • 203 Views
  • 6 CrossRef citations
  • 0Altmetric
A safety review of approved intrathecal analgesics for chronic pain management
Alan Chalil, Michael D. Staudt, Tessa A. Harland, Elizabeth M. Leimer, Ravneet Bhullar & Charles E. Argoff
Pages: 439-451
Published online: 08 Mar 2021
AbstractforA safety review of approved intrathecal analgesics for chronic pain management | Full Text | References | PDF (413.5 KB) | EPUB
  • 403 Views
  • 4 CrossRef citations
  • 0Altmetric
The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Anastasios G. Konstas, Antoine Labbé, Andreas Katsanos, Frances Meier-Gibbons, Murat Irkec, Konstadinos G. Boboridis, Gábor Holló, Julián García-Feijoo, Gordon N. Dutton & Christophe Baudouin
Pages: 453-466
Published online: 21 Jan 2021
AbstractforThe treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability | Full Text | References | PDF (1.4 MB) | EPUB
  • 311 Views
  • 12 CrossRef citations
  • 0Altmetric

Original Research

Article
A systematic review, meta-analysis and meta-regression evaluating the adverse reactions to erenumab in the preventive treatment of migraine
Lanfranco Pellesi, Roberto De Icco, Hassan Youssef Alawie, Morten Andersen, David Liang, Sarkhan Amirguliyev, Mohammad Al-Mahdi Al-Karagholi, Faisal Mohammad Amin & Maurizio Sessa
Pages: 467-474
Published online: 29 Dec 2020
AbstractforA systematic review, meta-analysis and meta-regression evaluating the adverse reactions to erenumab in the preventive treatment of migraine | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
  • 544 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathy
Daniel G. Dauner & Joel F. Farley
Pages: 475-480
Published online: 26 Mar 2021
AbstractforComparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathy | Full Text | References | PDF (764.3 KB) | EPUB | Supplemental
  • 387 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study
Elaine Kingwell, Tingting Zhang, Feng Zhu, Randy Walld, Robert Carruthers, Charity Evans, Ruth Ann Marrie & Helen Tremlett
Pages: 481-487
Published online: 06 Jan 2021
AbstractforShort-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study | Full Text | References | PDF (289.4 KB) | EPUB | Supplemental
  • 421 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data
Abdulaali R. Almutairi, Brian L. Erstad, Ali McBride, Marion Slack & Ivo Abraham
Pages: 489-497
Published online: 25 Jan 2021
AbstractforImmune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data | Full Text | References | PDF (608.6 KB) | EPUB | Supplemental
  • 336 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles